What's new

Filters: reports
x
Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

VALUE ADDED MEDICINES ONLINE SUMMIT Empowering the healthcare community by improving existing treatments

23 April 2021

Report

Open

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

10 February 2021

Report

Open

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Report

Open

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

Read more

COVID-19 “Round 2” – Findings & way forward (Kearney)

22 June 2020

Report

Open

Perceptions and recommendations of physicians/KOLs on value added medicines

21 November 2019

Report

Open

Improving healthcare delivery in hospitals by optimized utilization of medicines

7 October 2019

Report

Open

A digital future for value added medicines

24 September 2019

Policy, Report

Open

Calls to action to improve access to value added medicines

26 February 2019

Policy, Report

Open

Case Studies for Value Added Medicines. Unlocking the potential of patient-centric continuous innovation

26 February 2019

Policy, Report

Open

Subscribe to our newsletter